Profile
Dennis J. Selkoe is an American physician-scientist renowned for his work on the molecular pathogenesis of Alzheimer's disease, particularly the role of amyloid-beta peptides in disease biology. He has been a long-time professor of neurology at Harvard Medical School and a senior investigator at Brigham and Women's Hospital. His research has significantly influenced the understanding of amyloid biology and the development of therapeutic strategies for neurodegenerative diseases. In SEC filings, he is associated with Prothena Corp Public Ltd Co, indicating a professional connection to that company in the context of regulatory disclosures. Outside of SEC contexts, Selkoe is widely recognized in neuroscience for foundational work on amyloid precursor protein processing and amyloid-beta’s involvement in Alzheimer's disease.
| Role | Insider |
|---|---|
| Notability | 70/100 |
| Links | Wikipedia |
Board memberships
- Prothena Corp Public Ltd Co
Awards & honors
- Contributed to the foundational understanding of amyloid-beta peptide in Alzheimer's disease
- Longtime professor of neurology at Harvard Medical School and senior investigator at Brigham and Women's Hospital
- Influenced the field of Alzheimer's research and amyloid biology through extensive publications